Format

Send to

Choose Destination
See comment in PubMed Commons below
Cell Metab. 2010 Jan;11(1):35-46. doi: 10.1016/j.cmet.2009.11.010.

Mechanisms of life span extension by rapamycin in the fruit fly Drosophila melanogaster.

Author information

1
Institute of Healthy Ageing, Department of Genetics, Evolution and Environment, University College London, UK.

Abstract

The target of rapamycin (TOR) pathway is a major nutrient-sensing pathway that, when genetically downregulated, increases life span in evolutionarily diverse organisms including mammals. The central component of this pathway, TOR kinase, is the target of the inhibitory drug rapamycin, a highly specific and well-described drug approved for human use. We show here that feeding rapamycin to adult Drosophila produces the life span extension seen in some TOR mutants. Increase in life span by rapamycin was associated with increased resistance to both starvation and paraquat. Analysis of the underlying mechanisms revealed that rapamycin increased longevity specifically through the TORC1 branch of the TOR pathway, through alterations to both autophagy and translation. Rapamycin could increase life span of weak insulin/Igf signaling (IIS) pathway mutants and of flies with life span maximized by dietary restriction, indicating additional mechanisms.

PMID:
20074526
PMCID:
PMC2824086
DOI:
10.1016/j.cmet.2009.11.010
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science Icon for PubMed Central
    Loading ...
    Support Center